Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ascendis Pharma A (ASND) over the last 13 years, with Q4 2024 value amounting to 0.09.

  • Ascendis Pharma A's Equity Ratio rose 4921.73% to 0.09 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.09, marking a year-over-year increase of 4921.73%. This contributed to the annual value of 0.09 for FY2024, which is 4921.73% up from last year.
  • According to the latest figures from Q4 2024, Ascendis Pharma A's Equity Ratio is 0.09, which was up 4921.73% from 0.18 recorded in Q4 2023.
  • Over the past 5 years, Ascendis Pharma A's Equity Ratio peaked at 0.91 during Q3 2020, and registered a low of 0.18 during Q4 2023.
  • For the 5-year period, Ascendis Pharma A's Equity Ratio averaged around 0.5, with its median value being 0.49 (2022).
  • Per our database at Business Quant, Ascendis Pharma A's Equity Ratio plummeted by 17302.64% in 2023 and then soared by 4921.73% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Equity Ratio (Quarter) stood at 0.52 in 2020, then fell by 14.77% to 0.44 in 2021, then crashed by 45.36% to 0.24 in 2022, then crashed by 173.03% to 0.18 in 2023, then soared by 49.22% to 0.09 in 2024.
  • Its last three reported values are 0.09 in Q4 2024, 0.18 for Q4 2023, and 0.24 during Q4 2022.